GRO a Rat

GRO-Alpha Rat Recombinant (CXCL1)
Shipped with Ice Packs
In Stock

Description

Biological Function and Activity

GRO-α Rat functions as a potent chemokine in inflammatory and immune responses:

ActivityDetailsSource
Neutrophil ChemotaxisConcentrations of 10–100 ng/mL induce chemotaxis in rat neutrophils
CXCR1/CXCR2 ActivationBinds CXCR2 at lower concentrations than CXCR1
Hematopoietic SuppressionInhibits progenitor cell proliferation at higher doses

Mechanistic Insights

  • Acts synergistically with other chemokines (e.g., CINC-2α, CINC-3) to amplify neutrophil recruitment .

  • Produced by macrophages, endothelial cells, and epithelial cells during inflammation .

Production and Reconstitution

GRO-α Rat is commonly produced via recombinant expression in E. coli and requires careful handling:

ParameterDetailsSource
Reconstitution0.1–1.0 mg/mL in sterile water
Storage-20°C (lyophilized), 2–8°C (reconstituted)
StabilityAvoid freeze-thaw cycles; add BSA/HSA as a carrier

Key Considerations

  • Lyophilized formulations are stable for 1 year at -20°C .

  • Biological activity is validated using chemotaxis assays with rat neutrophils .

Research Applications

GRO-α Rat is widely utilized in studies of inflammation, immune response, and disease modeling:

ApplicationDetailsSource
Inflammatory ModelsQuantified in serum/plasma using ELISA kits (e.g., IBL’s Rat GRO/CINC-1 Assay Kit)
Neutrophil MigrationDose-dependent chemotaxis assays in vitro
Comparative StudiesContrasted with human GRO-α to study species-specific immune mechanisms

Notable Findings

  • Serum GRO-α levels correlate with neutrophil recruitment in rat injury models .

  • Cotton rat GRO (homologous to rat GRO-α) binds CXCR2 with higher affinity than CXCR1, mirroring human GRO-α behavior .

Comparison with Related Rat Chemokines

ChemokineCXCL NameAmino AcidsSequence Homology (vs. GRO-α Rat)Source
GRO-α (CINC-1)CXCL172–73
GRO-β (CINC-3)CXCL273~75%
GRO-γ (CINC-2α)CXCL369~76%

Functional Differences

  • GRO-β/CINC-3: Exhibits distinct binding kinetics and is involved in myeloid progenitor suppression .

  • GRO-γ/CINC-2α: Shares receptor specificity (CXCR2) but differs in tissue expression patterns .

Product Specs

Introduction
Chemokine (C-X-C motif) ligand 1 (CXCL1), also known as GRO1 oncogene, Neutrophil-activating protein 3 (NAP-3), and melanoma growth stimulating activity, alpha (MSGA-α), is a small cytokine in the CXC chemokine family. It is secreted by human melanoma cells and has mitogenic properties, playing a role in melanoma pathogenesis. CXCL1 is produced by macrophages, neutrophils, and epithelial cells and acts as a neutrophil chemoattractant. It is involved in spinal cord development, where it inhibits the migration of oligodendrocyte precursors. Additionally, CXCL1 contributes to angiogenesis, inflammation, wound healing, and tumorigenesis. Its effects are mediated by signaling through the chemokine receptor CXCR2. The gene encoding CXCL1 is found on human chromosome 4, clustered with genes for other CXC chemokines.
Description
Recombinant Rat CXCL1, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 73 amino acids. With a molecular weight of 7.8 kDa, Rat CXCL1 is purified through proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered White lyophilized powder.
Formulation
Lyophilized from a 0.2 μm filtered solution at a concentration of 1 mg/ml in 20 mM phosphate buffer (PB), pH 7.4, with 150 mM NaCl.
Solubility
Reconstitute the lyophilized CXCL1 in sterile 18 MΩ-cm H2O to a concentration of at least 100 µg/ml. This solution can be further diluted in other aqueous solutions.
Stability
Lyophilized CXCL1 remains stable at room temperature for up to 3 weeks. However, for extended storage, it is recommended to store desiccated below -18°C. Reconstituted CXCL1 should be stored at 4°C for 2-7 days. For long-term storage, add a carrier protein (0.1% HSA or BSA) and store below -18°C. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 97.0% as determined by: (a) RP-HPLC analysis and (b) SDS-PAGE analysis.
Biological Activity
The biological activity of Rat CXCL1 is evaluated based on its ability to chemoattract rat neutrophils. Using a concentration range of 10-100 ng/ml, the specific activity corresponds to 10,000-100,000 IU/mg.
Synonyms
Growth-regulated protein alpha, CXCL1, Melanoma growth stimulatory activity, MGSA, Neutrophil-activating protein 3, NAP-3, GRO-alpha(1-73), chemokine (C-X-C motif) ligand 1, GRO1, GROa, SCYB1, MGSA-a, MGSA alpha.
Source
Escherichia Coli.
Amino Acid Sequence
APVANELRCQ CLQTVAGIHF KNIQSLKVMP PGPHCTQTEV IATLKNGREA CLDPEAPMVQ KIVQKMLKGV PK.

Q&A

What makes rats suitable models for human-related research compared to other rodents?

Laboratory rats, particularly Sprague-Dawley (SD) strains, serve as excellent models for human-related research due to their well-characterized physiology and genetics. Unlike mice, rats have been extensively used in developmental and reproductive physiology and endocrinology research, making them more thoroughly characterized in these fields. Rats are considered adequately sensitive for detecting human-relevant responses and represent a human-equivalent model for cancer research and toxicology studies . The rat's digestive system is remarkably similar to humans, allowing for nutritional and metabolic studies with greater translational value . Furthermore, rats demonstrate more complex behavioral patterns than mice, enabling more sophisticated cognitive and behavioral assessments .

Methodology note: When selecting between rat and mouse models, researchers should consider the specific research question, historical data availability, and physiological relevance to human systems rather than simply following current trends.

Why has there been a decline in rat-based research, and what are the implications for scientific progress?

Statistical analysis shows that rat usage in aging research peaked in 1992 with a rat-to-mouse paper ratio of 3.0, but by 2018, this ratio had nearly reversed as mice became the predominant research model . This shift occurred despite the rat's numerous advantages in specific research domains. The decline can be attributed to:

  • The earlier development of genetic modification techniques in mice

  • Lower housing costs for mice

  • Availability of mouse-specific reagents and tools

  • Institutional momentum and research trends

The implications of this shift include potential gaps in our understanding of certain disease mechanisms that are better modeled in rats, particularly in areas of cardiovascular disease, neurological disorders, and metabolic conditions. Researchers have begun advocating for "bringing back the rat" to complement mouse studies and address these scientific gaps .

How should researchers design integrated studies that maximize data collection while minimizing animal use with rat models?

An optimal integrated study design follows a stepwise process that incorporates multiple endpoints within a single protocol. This approach aligns with the 3Rs principle (replacement, reduction, refinement) while generating comprehensive data . Key methodology components include:

  • Developmental exposure assessment: Include prenatal, lactational, and neonatal exposure windows within the same study design.

  • Lifespan evaluation: Monitor rats throughout their entire lifespan (2-3 years) to capture long-term effects .

  • Parallel satellite experiments: Use cohorts from the same generation to evaluate:

    • Biomarkers of exposure/effect

    • System-specific responses

    • Metabolic alterations

    • Endocrine disturbances

  • Standardized endpoints: Incorporate priority endpoints from Economic Co-operation and Development and National Toxicology Program guidelines on:

    • Carcinogenicity

    • Chronic toxicity

    • Developmental toxicity

    • Reproductive toxicity

This integrated approach provides sufficient data on multiple windows of susceptibility particularly relevant for risk assessments and public health decision-making .

What are the optimal nutritional and environmental conditions for maintaining research rats to ensure reproducible growth patterns?

Maintaining standardized growth conditions is critical for research validity. Based on established protocols, optimal conditions include:

Nutritional requirements:

  • Structured diet with defined macronutrient composition

  • Control for caloric intake (especially important in comparative studies)

  • In nutrition studies like The Great Grow Along, precise measurement of nutritional components is essential (e.g., comparing milk versus sugar water beverages of equal caloric content)

Environmental conditions:

  • Temperature: 20-24°C

  • Humidity: 40-60%

  • Light/dark cycle: Standardized 12-hour cycles

  • Housing: Appropriate cage size based on animal numbers (minimum space requirements per animal)

  • Social environment: Rats are social animals requiring group housing when possible

Monitoring parameters:

  • Regular weight measurements (daily or weekly depending on study phase)

  • Food and water consumption tracking

  • Behavioral assessment

  • Health monitoring

How can researchers effectively interpret contradictory data when comparing Cotton Rat GRO protein functions with human chemokine analogs?

When faced with contradictory results between Cotton Rat GRO protein studies and human chemokine research, researchers should implement a systematic comparative analysis approach:

  • Sequence homology assessment: Cotton rat GRO shares approximately 77% amino acid sequence identity with human GRO alpha/CXCL1, 75% with GRO beta/CXCL2, and 70% with GRO gamma/CXCL3 . These differences may account for functional variations.

  • Receptor activation thresholds: Cotton rat GRO, similar to human GRO alpha, requires a concentration approximately one order of magnitude higher to activate CXCR1 compared to CXCR2 . This differential activation may explain conflicting results.

  • Cross-species validation: Verify findings using multiple species models when possible, as cotton rat GRO has been shown to bind and activate both mouse chemokine receptors CXCR1 and CXCR2 .

  • Production cell variance: Consider that cotton rat GRO, like in other rodents, is produced by various cell types including macrophages, endothelial cells, fibroblasts, astrocytes, neutrophils, keratinocytes, and intestinal epithelium . Source cell differences may impact protein function.

  • Experimental context: Evaluate whether discrepancies arise from differences in experimental systems, reagent quality, or methodological variations rather than true biological differences.

The EC50 for cotton rat GRO effects is typically in the range of 0.4-2 ng/mL, providing a reference point for concentration-dependent studies .

What are the key considerations when designing long-term toxicity studies using rat models compared to shorter acute exposure protocols?

Long-term toxicity studies with rats require fundamentally different design considerations than acute studies:

Study duration planning:

  • Consider the rat's typical lifespan (2-3 years)

  • Plan for a minimum study duration of 4 weeks for initial growth effects

  • For chronic toxicity or carcinogenicity assessment, studies should extend to at least 6 months and ideally longer

Cohort design and sampling strategy:

  • Implement time-course sampling to capture temporal changes

  • Include satellite groups for interim assessments without compromising primary endpoint groups

  • Account for natural attrition (approximately 20-30% over 2 years)

Multiple endpoints integration:

  • Layer multiple assessments within the same study design

  • Include developmental exposures and long-term outcomes

  • Generate information on a broad spectrum of endpoints

Specific rat strain selection criteria:

  • Choose strains with "low fecundity or a well-known high incidence of spontaneous developmental defects"

  • Select strains with "acceptable survival rate for the long-term study"

  • Sprague-Dawley rats meet these criteria and are recommended by OECD guidelines 443 and 453

Statistical power calculations:

  • Account for the expected effect size and variability over extended periods

  • Consider interim sacrifice points when calculating initial sample size

  • Plan for sufficient statistical power at each time point despite attrition

How have historical trends in rat versus mouse usage affected biomedical research outcomes, and what methodological adjustments should researchers consider?

Historical analysis reveals significant shifts in rodent model preference over the past six decades:

DecadeRat-to-Mouse Paper RatioKey Research Trends
1960s~1.0 (equal usage)Foundational physiological studies
1970sIncreasing rat usageExpansion of toxicological research
19923.0 (peak rat usage)Dominance of rat physiological models
2018~0.33 (mouse dominance)Genetic and molecular emphasis

This shift has created several methodological challenges that researchers should address:

  • Data integration challenges: Historical rat data may not easily integrate with newer mouse-based findings, creating disconnected literature bases.

  • Physiological relevance gaps: Mice and rats differ in key physiological systems relevant to aging, metabolism, and disease progression .

  • Translational inconsistencies: Some human conditions may be better modeled in rats than mice, creating potential translational gaps in current research.

Methodological adjustments recommended:

  • Model-appropriate hypothesis testing: Formulate hypotheses that match the physiological strengths of each model.

  • Cross-species validation: Verify key findings across both rat and mouse models before translating to human applications.

  • Historical data integration: Develop systematic approaches to integrate historical rat-based findings with contemporary mouse studies.

  • Complementary study designs: Design research programs that leverage the strengths of both models rather than relying exclusively on either .

What are the key physiological and metabolic differences between laboratory rat strains that impact experimental design and data interpretation?

Understanding strain differences is crucial for research validity and reproducibility:

Sprague-Dawley (SD) rats:

  • Recommended by OECD and NTP guidelines

  • Show adequate sensitivity for toxicological studies

  • Have acceptable survival rates for long-term studies

  • Demonstrate relatively low spontaneous tumor rates in control groups

  • Have digestive systems similar to humans, making them suitable for nutritional research

Other commonly used strains (comparative considerations):

  • Fisher 344: Higher sensitivity to certain carcinogens but shorter lifespan

  • Wistar: Generally robust but with strain-specific metabolic characteristics

  • Long-Evans: Better visual acuity, often used in behavioral studies

Key physiological differences impacting experimental design:

  • Growth rates and developmental milestones vary between strains

  • Baseline tumor incidence differs significantly

  • Metabolic enzyme profiles show strain-specific patterns

  • Behavioral characteristics and stress responses vary

  • Reproductive parameters and hormonal cycling show strain differences

These differences necessitate careful strain selection based on the specific research question and consistent use of the same strain throughout a research program to ensure comparable results.

How can researchers implement the 3Rs (Replacement, Reduction, Refinement) principles while maintaining scientific rigor in rat-based studies?

Implementing the 3Rs while maintaining scientific validity requires thoughtful experimental design:

Replacement strategies:

  • Use in vitro or computational methods for preliminary screens before moving to rat models

  • Consider whether simpler organisms could answer the research question

  • Implement organ-on-chip technologies for specific physiological questions

Reduction approaches:

  • Integrate multiple endpoints into a single study design as demonstrated in comprehensive toxicological assessments

  • Utilize statistical methods that maximize information from smaller sample sizes

  • Implement factorial designs to simultaneously test multiple variables

  • Apply longitudinal study designs with repeated measurements on the same animals

Refinement methods:

  • Ensure proper housing conditions with appropriate enrichment

  • Implement refined handling techniques to reduce stress

  • Use non-invasive monitoring technologies whenever possible

  • Apply refined surgical techniques and appropriate analgesia

  • Train staff thoroughly in humane techniques

Maintaining scientific rigor while implementing these principles requires:

  • Careful power calculations to ensure adequate sample sizes

  • Rigorous randomization and blinding procedures

  • Comprehensive reporting of all experimental details

  • Pre-registration of study protocols to prevent bias

  • Implementation of standardized assessment criteria

What facility and housing requirements are essential for longitudinal rat studies, particularly those focused on growth and development?

Longitudinal studies focusing on rat growth and development require specialized facilities and housing considerations:

Facility requirements:

  • Consistent temperature (20-24°C) and humidity (40-60%) control systems with minimal fluctuation

  • Reliable ventilation systems providing 10-15 air changes per hour

  • HEPA filtration for specific pathogen-free conditions when required

  • Light control systems capable of maintaining consistent light/dark cycles

  • Noise control measures to minimize stress

  • Dedicated quarantine areas for new animals

Housing specifications:

  • Appropriate cage sizes that accommodate growth over time:

    • Minimum 800 cm² floor area for 2-3 adult rats

    • Height minimum of 18-20 cm

  • Material selection that allows for:

    • Easy sanitization

    • Resistance to gnawing

    • Minimal absorption of potential chemical exposures

  • Environmental enrichment appropriate for developmental stage

Monitoring systems:

  • Automated systems for continuous environmental parameter monitoring

  • Video recording capabilities for behavioral assessment

  • Computerized record-keeping for tracking growth metrics

  • Systems for measuring food and water consumption

Special considerations for The Great Grow Along type studies:

  • Facilities must accommodate caging supplies provided by the program

  • Space for proper setup of control and experimental conditions

  • Capacity to house purpose-bred rodents from credible breeding facilities

  • Facilities for preparing specialized diets (e.g., sugar water beverages of equal calories to milk)

What are the standardized protocols for measuring and analyzing growth patterns in laboratory rats across different developmental stages?

Standardized growth assessment in laboratory rats follows established protocols that vary by developmental stage:

Prenatal growth assessment:

  • Ultrasound measurements of fetal parameters

  • Post-mortem measurements following humane euthanasia of pregnant dams at specific gestational days

  • Wet and dry weight measurements of specific organs

  • Crown-rump length measurements

Postnatal growth (neonatal to weaning):

  • Daily body weight measurements (preferably at the same time each day)

  • Length measurements (nose-to-tail base) using standardized positioning

  • Developmental milestone documentation (eye opening, ear unfolding, incisor eruption)

  • Organ weight-to-body weight ratios for specific tissues at designated timepoints

Post-weaning to adult growth:

  • Weekly body weight measurements following standardized procedures

  • Body composition analysis using:

    • Dual-energy X-ray absorptiometry (DEXA)

    • Nuclear magnetic resonance (NMR)

    • Computed tomography (CT) for advanced studies

  • Food intake monitoring using metabolic cages or weighing food before and after feeding periods

Data analysis methodologies:

  • Growth curve fitting using established mathematical models:

    • Gompertz function

    • Logistic growth equation

    • von Bertalanffy growth model

  • Calculation of growth rate parameters:

    • Absolute growth rate

    • Specific growth rate

    • Instantaneous growth rate

  • Statistical analysis accounting for litter effects and other variables

What specialized techniques are required for working with Cotton Rat GRO protein in experimental settings?

Working with Cotton Rat GRO protein requires specific technical expertise and methodological considerations:

Protein handling and preparation:

  • Proper reconstitution protocols: For lyophilized products, reconstitute at 25 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin for standard preparations, or at 100 μg/mL in sterile PBS for carrier-free preparations

  • Storage requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles to maintain protein integrity

  • Carrier considerations: Understand the distinction between preparations with bovine serum albumin (BSA) as a carrier protein versus carrier-free versions

Experimental applications:

  • Concentration considerations: The EC50 for cotton rat GRO effects is typically 0.4-2 ng/mL, providing guidance for experimental dosing

  • Receptor activation studies: Cotton rat GRO binds and activates both mouse chemokine receptors CXCR1 and CXCR2, but requires approximately 10-fold higher concentration to activate CXCR1 compared to CXCR2

  • Cell type considerations: Account for cell-type specific responses, as cotton rat GRO is produced by various cell types including macrophages, endothelial cells, fibroblasts, astrocytes, neutrophils, keratinocytes, and intestinal epithelium

Technical validation methods:

  • Appropriate positive and negative controls for each experimental system

  • Validation across multiple cell types and receptor systems

  • Dose-response curves to establish biological activity in each experimental system

  • Comparison with human GRO proteins (α, β, γ) for translational research

Product Science Overview

Structure and Function

CXCL1 is characterized by the presence of a conserved glutamic acid-leucine-arginine (ELR) motif. This motif is crucial for its function, as it allows CXCL1 to bind to its receptor, CXCR2 . The binding of CXCL1 to CXCR2 triggers a series of intracellular signaling pathways that lead to the migration and activation of neutrophils .

Biological Role

CXCL1 plays a significant role in the inflammatory response. It is produced by various cell types, including macrophages, epithelial cells, and fibroblasts, in response to inflammatory stimuli . Once released, CXCL1 acts as a chemoattractant, guiding neutrophils to the site of infection or injury. This process is essential for the clearance of pathogens and the initiation of tissue repair .

Clinical Significance

High levels of CXCL1 have been associated with various pathological conditions, including cancer and chronic inflammatory diseases . For instance, elevated CXCL1 expression has been linked to advanced stages of uterine cervical cancer and worse survival outcomes . In cancer, CXCL1 can promote tumor growth and metastasis by enhancing the migration and invasion of cancer cells .

Research Applications

The rat recombinant version of CXCL1 is widely used in research to study its role in different biological processes and disease models. It is particularly useful in experiments involving neutrophil migration and activation, as well as in studies exploring the molecular mechanisms underlying inflammation and cancer progression .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.